The number-one rated TV health show in the U.S.," Dr. Oz," has featured white kidney bean extract in two separate episodes, as well as in three blogs over the last several months. While the positive coverage has contributed greatly to recognition of the ingredient, Pharmachem Laboratories, developer of Phase 2 white kidney bean extract, is concerned about consumer confusion caused by generic white kidney bean extracts.
“We are ecstatic over the coverage,” said Mitch Skop, director of new product development for Pharmachem. “We worked with Dr. Oz’s diet and fitness expert, Lisa Lynn, providing background for her interviews, and are pleased with the attention. However, of late we have become concerned about interest in new products labeled simply as 'white kidney bean extract.'
“Simple, generic white kidney bean extracts do not offer adequate potency or stability to perform like Phase 2®," he emphasized, "and will not provide the benefits nor the safety as described on the Dr Oz program."
The coverage on "Dr. Oz" was generated by the physician's review of the research, which he said impressed him. “Phase 2 is the first clinically studied extract of the white kidney bean shown to reduce starch digestion and aid in weight control. It is the only white bean extract backed by numerous clinical studies for efficacy and is GRAS," described Skop. "Generic white kidney beans have no similar studies, and thus cannot make claims about starch reduction or weight control--nor are there any guarantees of the generic ingredient’s purity."
According to Skop, Pharmachem is working to address the issue and has requested that Dr. Mehmet Oz reference the Phase 2 brand name in future stories about white kidney bean extract either on his TV show, "Dr. Oz," in his blog and on his website. In the meantime the company is launching a new marketing program to the trade and consumers, designed to educate them on the benefits of its popular brand, Phase 2 Carb Controller.
‘Ultimately, it’s about making sure the customer and the consumer are getting the proper information about what they are buying, and aren’t being fooled by imitations riding on our research," added Skop. “Unfortunately, it is a phenomenon that occurs all too often in our industry.”